A new dawn for upfront autologous SCT in NK/T-cell lymphomas: One more step forward in reasoning. Elverdi T, Hiyamli MF, Sahin B, Eskazan AE, et al. Int J Cancer 2022;151:661-664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elverdi T, Hiyamli MF, Sahin B, Eskazan AE, et al. A new dawn for upfront autologous SCT in NK/T-cell lymphomas: One more step forward in reasoning. Int J Cancer 2022;151:661-664.
PMID: 35678217